Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.

This is the first study in people to test a new drug called MG2512 injection for advanced solid tumors that have stopped responding to standard treatments. Researchers will give the drug to about 116 adults to check its safety, how the body processes it, and look for early signs …